BizNews BizNews Radio

Mark Ingham's high conviction buy call: Ever expensive Aspen suddenly cheap

Loading player...
After peaking at almost R450 early last year, the share price of Aspen Pharmacare has since been in steady retreat and is currently trading below R300. But while traders have been seeking shelter, independent investment analyst Mark Ingham is attracted by Mr Market's depression. He now regards Aspen shares as an excellent buying opportunity, rating his call as "high conviction". Ingham puts Aspen's fair value at R390 a share which means the current price offers today's buyers a significant margin of safety. In this in-depth interview Ingham unpacks the attraction of the R130bn market cap stock which has grown into a multinational operation with only around one fifth of its business in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices
2 Nov 2016 2AM English South Africa Investing · Business News

Other recent episodes

Solly Moeng: “It’s the list of devils”

“If we're going to look for angels in this stuff, we're not going to find angels. It's the list of the devils, it's where do we choose, what is the thing to focus on, the least worst thing to focus on.” These are the words of political commentator Solly Moeng…
1 Oct 9AM 13 min

GBV suspects on the run | Barry Bateman

The Private Prosecution Unit of AfriForum has taken up a number of cold cases in which the police have failed to trace or arrest or re-arrest known suspects. In this interview with Chris Steyn, the unit’s Barry Bateman, reveals details of some of those cases as well as the responses…
1 Oct 6AM 19 min

David Lupafya: the Land Bank backed black farmers, then pulled the rug

David Lupafya spent 25 years at AT&T, Microsoft and Lockheed Martin before coming home to grow grain on 1,300 hectares outside Potchefstroom. He did what careful farmers do: planned a season ahead and put more than R5 million of his own money down on tractors, a combine and implements, counting…
30 Sep 11AM 29 min
All episodes